Clinical Trial Update: A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates the study evaluating Hemay005 biomarkers in adults with chronic obstructive pulmonary disease is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Hemay005

Snippet

Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd | Conditions: COPD (Chronic Obstructive Pulmonary Disease) | Phase 2 | Status: NOT_YET_RECRUITING